Literature DB >> 17042385

Plasma concentration of vitamin C in dogs with a portosystemic shunt.

Nobuya Hishiyama1, Hideki Kayanuma, Tohru Matsui, Hideo Yano, Tsunenori Suganuma, Masayuki Funaba, Hiroshi Fujise.   

Abstract

Most mammals, including dogs, synthesize vitamin C in the liver. We measured the plasma concentration of vitamin C to assess the body vitamin C status in 15 dogs with a portosystemic shunt (PSS). The plasma biochemical parameters indicated liver abnormalities in all the dogs. In contrast, the plasma concentration of vitamin C ranged from 2.21 to 9.03 mg/L in the 15 dogs and was below the reference range (3.2 to 8.9 mg/L) in only 2 dogs. These findings suggest that vitamin C status is not impaired in dogs with PSS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17042385      PMCID: PMC1562529     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

Review 1.  Synthesis and some major functions of vitamin C in animals.

Authors:  I B Chatterjee; A K Majumder; B K Nandi; N Subramanian
Journal:  Ann N Y Acad Sci       Date:  1975-09-30       Impact factor: 5.691

2.  Iron status and erythrocyte volume in dogs with congenital portosystemic vascular anomalies.

Authors:  K W Simpson; D J Meyer; A Boswood; R N White; I E Maskell
Journal:  J Vet Intern Med       Date:  1997 Jan-Feb       Impact factor: 3.333

3.  8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.

Authors:  N Delanty; M P Reilly; D Pratico; J A Lawson; J F McCarthy; A E Wood; S T Ohnishi; D J Fitzgerald; G A FitzGerald
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

Review 4.  Vitamin C: newer insights into its biochemical functions.

Authors:  H Padh
Journal:  Nutr Rev       Date:  1991-03       Impact factor: 7.110

5.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Authors:  M Levine; C Conry-Cantilena; Y Wang; R W Welch; P W Washko; K R Dhariwal; J B Park; A Lazarev; J F Graumlich; J King; L R Cantilena
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions.

Authors:  R Levy; O Shriker; A Porath; K Riesenberg; F Schlaeffer
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

7.  Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man.

Authors:  M Nishikimi; R Fukuyama; S Minoshima; N Shimizu; K Yagi
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

8.  Ascorbate is an outstanding antioxidant in human blood plasma.

Authors:  B Frei; L England; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 9.  Ascorbic acid and carnitine biosynthesis.

Authors:  C J Rebouche
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

10.  Dietary fat type affects vitamins C and E and biomarkers of oxidative status in peripheral and brain tissues of golden Syrian hamsters.

Authors:  Concepción Sánchez-Moreno; Suzanne E Dorfman; Alice H Lichtenstein; Antonio Martín
Journal:  J Nutr       Date:  2004-03       Impact factor: 4.798

View more
  2 in total

1.  Persistent hypercobalaminemia three months after successful gradual attenuation of extrahepatic shunts in dogs: a prospective cohort study.

Authors:  Nausikaa Devriendt; Gonçalo Serrano; Dominique Paepe; Sophie Vandenabeele; Emmelie Stock; Hilde de Rooster
Journal:  BMC Vet Res       Date:  2022-01-06       Impact factor: 2.741

2.  Effects of administration of ascorbic acid and low-dose hydrocortisone after infusion of sublethal doses of lipopolysaccharide to horses.

Authors:  Melinda J Anderson; Alina S Ibrahim; Bruce R Cooper; Andrew D Woolcock; George E Moore; Sandra D Taylor
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.